EXECUTIVE COMMITTEE ON GLOBAL HEALTH AND HUMAN SECURITY
2007–Present
The Executive Committee on Global Health and Human Security is a unique public-private platform that facilitates the Japanese government’s policymaking on global health and public-private collaboration in that field. Under the chairmanship of former Minister of Health, Labour and Welfare Yasuhisa Shiozaki, the committee holds quarterly meetings to provide a venue for unofficial exchanges of views and information sharing among government ministries, academia, private companies, and civil society organizations in Japan. Global health experts from Japan and overseas are invited to speak at the meetings to offer their knowledge and advice.
The committee was initially launched in 2007 as the Working Group on Challenges in Global Health and Japan’s Contributions to prepare policy recommendations for the G8 Hokkaido Toyako Summit the following year. The committee is an integral part of the Global Health and Human Security Program of JCIE, which manages all aspects of the committee’s work.
WORKING GROUPS
In addition to its regular meetings, the following is a select list of some of the working groups and task forces established under the Executive Committee’s auspices:
Task Force on Global Action for Health System Strengthening
(2008–2009)
PROGRAM ACTIVITIES
Hiroshima G7 Global Health Follow-Up Initiative Kick-off Event: Reflections on the 2023 G7
June 27, 2023 | Online
This webinar is a kick-off for the Hiroshima G7 Global Health Follow-up Initiative, and aims to reflect on the 2023 G7 communique and past G7 commitments.
Hiroshima G7 Task Force: Recommendations for Promoting Global Solidarity Towards a More Resilient Health System
April 5, 2023 | Online
JCIE co-hosted a special webinar with Pandemic Action Network (PAN), and the University of Tokyo’s Institute for Future Initiatives to discuss JCIE’s Hiroshima G7 Global Health Task Force recommendati…
Hiroshima G7 Global Health Task Force Dialogue Series
February 1–10, 2023 | Online
In 2023, Japan will host the G7 Summit in Hiroshima. JCIE has established a Hiroshima G7 Global Health Task Force to make recommendations to the Japanese government on the G7 agenda for global health….
Hiroshima G7 Global Health Taskforce Roundtable Discussion
November 30, 2022 | Washington DC
In 2023, Japan will host the G7 Summit in Hiroshima. JCIE has established a Hiroshima G7 Global Health Task Force to make recommendations to the Japanese government on the G7 agenda for global health….
The Roles of Germany and Japan in Global Health IV
October 19, 2022 | Berlin and Online
Japanese and German politicians, policy experts, business leaders, and global health experts participated in a hybrid forum to utilize the countries’ bilateral relationship to discuss key issues in gl…
Launch of the G7 Global Health Task Force
August 10, 2022 | Japan
Ahead of the G7 Summit, JCIE has established the 2023 G7 Global Health Task Force under the Executive Committee on Global Health and Human Security to make recommendations to the Japanese government o…
Briefing on the ACT-Accelerator at the Special Session of the Executive Committee on Global Health and Human Security
May 19, 2021 | Virtual
On May 19th, ten leaders of the global health organizations that comprise the Access to COVID-19 Tools (ACT) Accelerator, as well as Ambassador Carl Bildt, WHO Special Envoy for ACT-Accelerator, joine…
Reformulating Japan's Global Health ODA to Meet Changing Global Needs
January 30, 2020 | Bangkok, Thailand
More than 30 senior government officials, health experts, and leaders from international organizations gathered to discuss the direction Japan should take to improve its developmental assistance for h…
Policy Recommendations for the 2016 G7 Summit in Japan: Toward Resilient and Sustainable Universal Health Coverage (UHC)
January 27, 2016 | Bangkok, Thailand
At this side event to the 2016 Prince Mahidol Award Conference (PMAC), members of JCIE’s Global Health Working Group (GHWG) presented their draft policy recommendations for the G7 Ise-Shima Summit in…
Dissemination Seminar in Africa—Global Action for Health System Strengthening
April 17–18, 2009 | Nairobi, Kenya
A final dissemination seminar for the Global Action for Health System Strengthening report was held in Nairobi, in collaboration with the African Medical and Research Foundation (AMREF), on April 17–1…
Dissemination Seminars in the United States—Global Action for Health System Strengthening
March 17–19, 2009 |
Two dissemination seminars for Global Action for Health System Strengthening were organized in Washington DC, one on March 17, 2009, that was organized in collaboration with the Center for Global Deve…
Dissemination Seminar in Asia—Global Action for Health System Strengthening
January 27, 2009 | Bangkok, Thailand
The primary goal of this seminar was to share with a broad group of global health stakeholders the outcomes of a recent report produced by an international task force of global health experts.
International Conference on Global Action for Health System Strengthening
November 3–4, 2008 | Tokyo, Japan
A high-level international conference was convened in Tokyo on November 3–4, 2008, to explore the creation of a global strategic framework for strengthening health systems in developing countries arou…
REPORTS
Global Health Multistakeholder Dialogue Recommendations to the G7 2024
Global Health Multistakeholder Dialogue
December 2023
FULL REPORT (EN) The final report of the Global Health Multistakeholder Dialogue: From Hiroshima to Puglia has been released. This report is a culmination of the independent, nonstate actor-led proce…
Hiroshima G7 Global Health Task Force Recommendations for the G7 Meetings in Japan
Hiroshima G7 Global Health Task Force
April 2023
This report, available in both English and Japanese, outlines the Task Force for Promoting Pharmaceutical and Medical Device Regulatory Harmonization in Asia’s strategy recommendations for a COVID-19…
JCIE's Hiroshima G7 Global Health Task Force Publishes Comments in the Lancet Ahead of G7 Meetings
April 4, 2023
The Lancet published a comment from the Hiroshima G7 Global Health Task Force, outlining the Task Force’s recommendations for tackling some of the main challenges in global health: advancing the resil…
A COVID-19 Emergency Response Strategy—Establishing Domestic Vaccine Development Capacity During a Public Health Emergency
Task Force for Promoting Pharmaceutical and Medical Device Regulatory Harmonization in Asia, Executive Committee on Global Health and Human Security
2021
This report, available in both English and Japanese, outlines the Task Force for Promoting Pharmaceutical and Medical Device Regulatory Harmonization in Asia’s strategy recommendations for a COVID-19…
Japan’s Global Health Diplomacy in the Post-COVID Era—The Paradigm Shift Needed on ODA and Related Policies
Special Commission on Japan’s Strategy on Development Assistance for Health
2020 & 2021
A report from a high-level commission organized by JCIE calls for the Japanese government to better coordinate and strategize its health ODA by creating a centralized “control tower” and to double fun…
Survey of Japanese Legislators: Attitudes on ODA and Global Health
Japan Center for International Exchange (JCIE)
June 2020
A JCIE survey of Japanese legislators finds that 80 percent of the 92 respondents favor steps to increase Japan’s official development assistance (ODA), with most prioritizing funding for health progr…
A UHC Approach to Harmonizing Asian Pharmaceutical and Medical Device Regulations
Task Force for Promoting Pharmaceutical and Medical Device Regulatory Harmonization in Asia, Executive Committee on Global Health and Human Security
2020
The recommendations of JCIE’s Task Force for Promoting Pharmaceutical and Medical Device Regulatory Harmonization in Asia examines specific areas Japan should tackle in order to promote regulatory har…
Recommendations on Formulating a Grand Design for Asian Pharmaceutical and Medical Device Regulatory Harmonization
Executive Committee on Global Health and Human Security, JCIE
2019
The recommendations of JCIE’s Task Force for Promoting Pharmaceutical and Medical Device Regulatory Harmonization in Asia highlight a need for regulatory harmonization and cross-sectoral cooperation.
Advancing a Global Health Agenda in the SDG Era: Enhancing Japan’s Leadership Role in 2019–2020
International Advisory Group on Global Health (IAG)
November 2018
This report details the insights from an ad hoc, 15-member “JCIE International Advisory Group on Global Health (IAG)” on the topic of supporting countries in implementing universal health coverage and…
Protecting Human Security: Proposals for the G7 Ise-Shima Summit in Japan
Global Health Working Group for the 2016 G7 Summit
May 21, 2016
This article shares policy recommendations to develop: global structures that enable effective preparedness for health emergencies, knowledge-sharing platforms for health system resilience and sustain…
Global Action for Health System Strengthening: Policy Recommendations to the G8
Task Force on Global Action for Health System Strengthening
2009
This report was submitted to the Japanese and Italian governments in January 2009 for consideration for the 2009 G8 Summit agenda.
EXECUTIVE COMMITTEE MEMBERS
CHAIR | |
Yasuhisa Shiozaki | Former Member, House of Representatives; Former Minister of Health, Labour and Welfare |
DIRECTOR | |
Isao Kano | President and CEO, JCIE |
SENIOR ADVISORS | |
Ichiro Aisawa | Member, House of Representatives |
Katsunobu Kato | Member, House of Representatives |
Norihisa Tamura | Member, House of Representatives |
MEMBERS | |
Takeshi Akahori | Director-General for Global Issues, Ministry of Foreign Affairs |
Daiho Fujii | Deputy Vice Minister for International Affairs, Ministry of Finance (MOF) |
Yasuhiro Fujiwara | Chief Executive, Pharmaceuticals and Medical Devices Agency (PMDA) |
Motohisa Furukawa | Member, House of Representatives |
Noriko Furuya | Member, House of Representatives |
Haruhiko Hirate | Executive Vice President, Dentsu Group, Inc. |
Naoki Ikegami | Professor emeritus, Keio University |
Hidetoshi Imamura | Executive Board Member, Japan Medical Association |
Sachiko Imoto | Vice President, Japan International Cooperation Agency (JICA) |
Masaki Inaba | Chair, Japan CSO Network on Global Health; Policy Advisor, Japan Civil Society Network on SDGs (SDGs Japan) |
Masamine Jimba | Emeritus Professor, The University of Tokyo |
Mayumi Katsube | Chairperson, JOICFP (Japanese Organization for International Cooperation in Family Planning) |
Yasushi Katsuma | Professor, Faculty of International Research & Education, Waseda University; Director, Institute for Global Health Policy Research (iGHP), National Center for Global Health and Medicine (NCGM) |
Kiyoshi Kita | Dean, School of Tropical Medicine and Global Health, Nagasaki University |
Kiyoshi Kodera | Board member, WaterAid Japan; Senior Research Associate, Overseas Development Institute |
Norihiro Kokudo | President, National Center for Global Health and Medicine |
Osamu Kunii | Executive Director and CEO, Global Health Innovative Technology Fund (GHIT) |
Kiyoshi Kurokawa | Adjunct Professor, National Graduate Institute for Policy Studies (GRIPS); Chairman, Health and Global Policy Institute |
Kenichi Matsumoto | Vice Chairman, The Japan Federation of Medical Devices Associations |
Yoshiro Matsuo | Vice President and Representative Director, Otsuka Pharmaceutical Co., Ltd. |
Haruo Naito | President and CEO, Eisai Co., Ltd. |
Yasuhide Nakamura | President, WHO Association of Japan |
Hiroki Nakatani | Visiting Professor, School of Medicine, Keio University |
Shigeru Omi | Representative Director, Japan Anti-Tuberculosis Association; Regional Director Emeritus, World Organization for Western Pacific Region (WPRO) |
Masami Sakoi | Medical Commissioner, Ministry of Health, Labour and Welfare |
Atsushi Seike | President, Japanese Red Cross Society |
Kenji Shibuya | CEO, Medical Excellence JAPAN |
Mizue Shiomi | Director-General, Research Promotion Bureau, Ministry of Education, Culture, Sports, Science and Technology (MEXT) |
Hideaki Shiroyama | Affiliated Faculty Member, Institute for Future Initiatives; Professor, Graduate School of Public Policy; Professor, Graduate Schools for Law and Politics, The University of Tokyo |
Tomofumi Sone | President, National Institute of Public Health |
Manabu Sumi | Councillor, Cabinet Agency for Infectious Disease Crisis Management, Cabinet Secretariat |
Hideo Suzuki | Ambassador for Global Health, Executive Director for Healthcare Policy, Cabinet Office |
Yukio Takasu | Special Adviser to the Secretary-General on Human Security, UN |
Isao Teshirogi | President and CEO, Shionogi & Co., Ltd. |
Naoko Yamamoto | Professor, Graduate School of International University of Health and Welfare |
Kenji Yasukawa | Representative Director, Chairman of the Board, Astellas Pharma Inc. |
FELLOWS | |
Naoki Kondo | Professor and Chair, Department of Social Epidemiology and Global Health, Graduate School of Medicine Public Health, Kyoto University |
Shuhei Nomura | Associate Professor, Department of Health Policy and Management, School of Medicine, Keio University; Assistant Professor, Department of Global Health Policy, Graduate School of Medicine, The University of Tokyo |
Haruka Sakamoto | Associate Professor, Department of Hygiene and Public Health, Division of Global Health, Tokyo Women’s Medical University |
| as of April 2024 |
The Executive Committee was founded by and is organized by JCIE with the generous support of the Bill & Melinda Gates Foundation.